C

cambio-group

browser_icon
Company Domain cambio.se link_icon
lightning_bolt Market Research

Cambio Healthcare Systems AB - Comprehensive Analysis Report



Summary


Cambio Healthcare Systems AB, widely known as Cambio, was established in 1993 in Linköping, Sweden. The company's core mission is to profoundly impact society by transforming and enhancing health and social care. It achieves this by delivering high-quality, open, and collaborative solutions designed to integrate with diverse ecosystems and align with evolving eHealth paradigms. Cambio continuously strives to innovate, ensuring its customers are equipped with future-ready health and social care capabilities today.

Cambio is a leading provider of Electronic Health Record (EHR) software and comprehensive eHealth solutions across the entire care continuum and social services sector. With a strong market presence in the Nordic region, the company is actively expanding its footprint across Europe. Cambio's solutions support a wide array of municipal and regional organizations, as well as private healthcare providers, through operational systems, electronic medical records, clinical decision support, intensive care systems, and vaccination systems. Its extensive deployment, serving 17 of Sweden's 21 regions and over 120 municipalities, positions Cambio as a key player in integrating and connecting the entire care chain within healthcare systems.

1. Strategic Focus & Objectives


Core Objectives


Cambio's strategic focus centers on driving digital transformation within health and social care by providing innovative and integrated eHealth solutions. The company aims to deliver cohesive solutions that empower healthcare professionals and enable safer, more accessible care for patients.

Comprehensive IT Support: Provision of end-to-end IT support spanning the entire healthcare ecosystem.
Interoperability and Data-Driven Solutions: Emphasis on interoperable, data-driven healthcare solutions to ensure seamless data continuity throughout the care chain, thereby enhancing efficiency and collaboration across care providers.
Patient-Centric Care: Designing solutions with a primary focus on the patient, promoting safety and improved outcomes.
Geographic Expansion: Expanding operations across the European market, building upon its robust leadership in the Nordics. This includes a recent agreement to deliver its COSMIC EHR system to Åland, marking entry into a new geographical market.
Continuous Innovation: Consistently advancing its offerings by anticipating future challenges and leveraging cutting-edge technology to provide customers with the most advanced healthcare technology.

Specialization Areas


The company specializes in:
Electronic Health Record (EHR) software.
Comprehensive eHealth solutions that cover the entire continuum of care and social services.
Specialized functionalities such as clinical decision support (CDS), intensive care systems, and vaccination systems.
Operational systems for municipal and regional organizations.

Target Markets


Cambio targets a broad range of healthcare and social care entities, including:
Municipal and regional organizations.
Private healthcare providers.
Hospitals, health centers, and specialist units.
Geographically, its primary markets include Sweden, Denmark, the UK, the Faroe Islands, Greenland, Iceland, New Zealand, and Åland.

2. Financial Overview


Funding History


Cambio Healthcare Systems AB has been owned by Sanolium AB since February 19, 2019. Sanolium AB is wholly owned by Sanolium Holding AB, which is part of Investcorp, a global investment company. Investcorp holds approximately 80% participating interest in Cambio, with the remaining approximately 20% primarily owned by employees and other stakeholders.

Prior to Investcorp's involvement, Valedo invested in Cambio in 2012 to accelerate its growth and development. During this period, founders Tomas Mora-Morrison and Håkan Mattsson reinvested in partnership with Valedo, maintaining significant minority shareholdings. A sales process commenced in late 2018, culminating in Cambio's divestment to Investcorp in February 2019. The founders and management team subsequently reinvested in Cambio in partnership with Investcorp.

Sanolium AB Group became public after issuing a corporate bond in September 2019. Cambio's business model primarily generates revenue through the sale of licenses, ongoing maintenance services, and product-related consultancy.

3. Product Pipeline


Cambio's product development is continuously enhancing and expanding the capabilities of its core eHealth solutions. Key developments and ongoing projects include:

Cambio COSMIC EHR System: Ongoing implementation projects include the Sussa procurement win in December 2018, which led to agreements with 17 of Sweden's 21 regions to utilize Cambio Group's software. A significant agreement in May 2024 involved delivering the Cambio COSMIC EHR system to Åland, under a contract spanning 10 plus 4 plus 4 years, inclusive of comprehensive implementation.
Cambio Viva: This operational system for municipalities is continuously undergoing development and implementation, currently serving over 40 municipalities.
Cambio CDS (Clinical Decision Support): Ongoing efforts are dedicated to the further development of its computerized clinical decision support system.
Integration of MittVaccin: Discussions are actively in progress with Cambio Group's customers regarding the MittVaccin solution, with 7 of the 17 regions having signed agreements to date.
Acquisition of Daintel: This acquisition demonstrates Cambio's strategy to expand its capabilities and market reach, with anticipated integration of Daintel's offerings or complementary solutions.
Acquisition of Leapscribe: In March 2025, Cambio acquired Leapscribe, an ambient scribe company, further enhancing its capabilities in healthcare documentation.
Remote Patient Monitoring (RPM): In January 2025, Cambio in collaboration with ImagineCare secured Sweden's largest RPM procurement, marking a significant entry into remote care solutions.

4. Technology & Innovation


Cambio leverages advanced technological platforms and proprietary solutions to maintain its competitive edge in the eHealth sector, focusing on open and collaborative solutions.

Technology Stack


Core Platforms: Cambio COSMIC (comprehensive healthcare information system), Cambio Viva (operational system for municipal care), Cambio CDS (clinical decision support), Cambio CIS (clinical information system), and Cambio Device Connectivity (CDC).
Foundational Technologies: The technology stack includes AngularJS for client-side development, OpenSearch for powerful search capabilities, and Apache ActiveMQ for messaging.
Operating Environments: Supports robust server environments with Red Hat Enterprise Linux and client-side operations on macOS.

Proprietary Developments


Cambio CDS: A proprietary clinical decision support system that integrates patient-specific data with evidence-based medical regulations to identify risk factors and guide optimal patient care. This involves advanced scientific methodologies for combining clinical data with medical evidence.
Cambio Device Connectivity (CDC): A specialized platform designed to collect, process, manage, and integrate real-time patient data from over 900 types of bedside medical devices from multiple manufacturers into a singular, cohesive platform. This capability highlights robust proprietary integration technology and data handling.

Technical Capabilities


OpenEHR International Partnership: Cambio is a partner of OpenEHR International, demonstrating a commitment to open standards and interoperability in healthcare information systems.
Certifications: The company's commitment to quality and safety is underlined by its adherence to international standards and possession of relevant certifications, including MDR certification for
Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI